Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00244686
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2020-11-25
First Post:
2005-10-25
Brief Title:
This Record Contains Information About the Mepolizumab Compassionate Use CU Product Activities 104317 CU and Long-Term Access Study of Mepolizumab in HES 201956A Long-term Access Programme for Subjects With Severe Asthma 112562 Expanded Access for Patients With Hypereosinophilic
Sponsor:
Organization:
GlaxoSmithKline
Study Design
Study Type:
EXPANDED_ACCESS
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
True
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
None
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: